Updated WHO criteria define mixed phenotype acute leukemia (MPAL) with more stringent diagnostic criteria than the formerly described entity biphenotypic acute leukemia (BAL). The changes in diagnostic criteria influence management by assigning weight to
William A. Hammond +5 more
doaj +2 more sources
Biological features and outcome of biphenotypic acute leukemia: a case series
BACKGROUND: Biphenotypic acute leukemia (BAL) is a distinct entity that is immunophenotypically defined by the European Group for the Immunological Classification of Leukemia (EGIL) scoring system and accounts for less than 5% of all acute leukemia cases.
Mirta Mikulic +8 more
doaj +2 more sources
Treatment of Acute Lymphoid Leukemia Refractory to Classic First-Line and Rescue Protocols [PDF]
Acute Lymphoblastic Leukemia is a very aggressive malignant disorder of lymphoid cells in adults, with recurrence (30 to 60% of the cases) after the initial treatment.
Flávia Tobaldini Russo +10 more
doaj +2 more sources
Uncommon CD markers in acute myeloid leukemia
This study was done to assess the unusual CD expression in 100 cases of acute myeloid leukemia from October 2016 to April 2018. The age limit was from 3 to 50 years.
Azad Abul Kalam +3 more
doaj +2 more sources
Polyradiculoneuritis revealing an acute monoblastic leukemia 5 [PDF]
Acute polyradiculoneuritis has been frequently reported in association with malignant disorders, especially those of the lymphoid system. To date, there have been no reported cases of acute monoblastic leukemia associated with this polyradiculopathy. The
Wafa Allam +2 more
doaj +3 more sources
Lineage switch in childhood leukemia. [PDF]
Abstract Lineage switch (LS) is a rare but aggressive immunophenotypic transformation of acute leukemia associated with limited therapeutic options and poor clinical outcome. Although LS has been increasingly recognized in the era of CD19‐directed immunotherapies, its biological basis remains incompletely understood.
Daugs K, Prazmo A, Roy A, Borkhardt A.
europepmc +2 more sources
INVESTIGATION OF THE PREVALENCE OF CANDIDURIA IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES IN HOMS – SYRIA [PDF]
The aim of this study was to investigate the incidence of candiduria in patients with hematologic malignancies, and identity its causative agents. The study included 100 patients with one of the following diseases: Acute myeloid leukemia (AML), Chronic ...
Rafah Alali +2 more
doaj +1 more source
Hypoplastic acute myeloid leukemia with aberrant lymphoid antigen expression and fusion: A rare case report and literature review [PDF]
Ewing sarcoma breakpoint region 1 ( EWSR1 ):: Fifth Ewing variant ( FEV )-positive acute leukemia is exceptionally rare, and its clinicopathological features, molecular profile, and optimal treatment remain poorly defined. Here, we report a case of acute
Wenxia Xia +10 more
doaj +2 more sources
Acute lymphoid leukemia developing in the course of Crohn's Disease: Are there any guilty agents? [PDF]
Anti-tumor necrosis factor-alpha drugs (anti-TNF-α), which are monoclonal antibodies, have revolutionized the treatment of severe and refractory inflammatory bowel disease in the last two decades.
SASANİ, HADİ +5 more
core +1 more source
Flow Cytometry-Guided Diagnosis of Cortical T-Lymphoblastic Lymphoma Presenting With a Massive Mediastinal Mass and Borderline Bone Marrow Involvement. [PDF]
ABSTRACT Background T‐cell lymphoblastic lymphoma (T‐LBL) and T‐cell acute lymphoblastic leukemia (T‐ALL) are considered a single biological entity, distinguished primarily by the extent of bone marrow infiltration. This distinction becomes diagnostically challenging in patients with borderline marrow blast counts and predominantly extramedullary ...
Glait-Santar C +3 more
europepmc +2 more sources

